Log in to save to my catalogue

Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney dise...

Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney dise...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4870615

Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease

About this item

Full title

Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2016-05, Vol.6 (1), p.26137-26137, Article 26137

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

D-Amino acids, the enantiomers of L-amino acids, are increasingly recognized as novel biomarkers. Although the amounts of D-amino acids are usually very trace in human, some of them have sporadically been detected in blood from patients with kidney diseases. This study examined whether multiple chiral amino acids would be associated with kidney fun...

Alternative Titles

Full title

Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4870615

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4870615

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/srep26137

How to access this item